Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

24.31
Delayed Data
As of Oct 20
 -0.08 / -0.33%
Today’s Change
15.55
Today|||52-Week Range
25.44
+28.42%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close24.39
Today’s open24.60
Day’s range24.22 - 24.72
Volume194,711
Average volume (3 months)305,654
Market cap$933.1M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+11.63%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.99

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.54+1.17%
EDITEditas Medicine Inc+0.06+0.25%
EPZMEpizyme Inc0.000.00%
----
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts